Jason W. Radford

Jason W. Radford is a declared insider of Genomic Health Inc, with filings sourced from SEC (Form 4). Between 16 February 2016 and 8 November 2019, the trades on record add up to 22 filings.

Sales make up the whole of the open-market record (10 sales, €1.0M). Outside the open market, there are 10 share grants. In 2019 alone, the filings show no purchases and 8 sales.

The newest entry dates from 14 November 2019: a transaction, in Genomic Health Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.